A few studies raised that the association between liver and pancreatic fat content could be confounded by major factors [9, 10] therefore we aimed to assess this association stratified by PNPLA3 rs738409 (missense variant), a major genetic risk factor for NAFLD development. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.